| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | SELL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.17▼ | 4.17▼ | 4.18▼ | 4.16▼ | 4.06▲ |
| MA10 | 4.17▼ | 4.19▼ | 4.15▼ | 4.10▲ | 4.16▼ |
| MA20 | 4.17▼ | 4.14▲ | 4.14▲ | 4.09▲ | 4.78▼ |
| MA50 | 4.19▼ | 4.12▲ | 4.17▼ | 4.29▼ | 3.76▲ |
| MA100 | 4.14▲ | 4.15▼ | 4.12▲ | 4.83▼ | 7.00▼ |
| MA200 | 4.13▲ | 4.12▲ | 4.15▼ | 3.85▲ | 23.59▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.002▲ | 0.009▲ | 0.031▲ | -0.114▼ |
| RSI | 39.759▼ | 50.068▲ | 49.805▼ | 48.998▼ | 47.976▼ |
| STOCH | 72.917 | 44.273 | 83.681▲ | 48.308 | 17.204▼ |
| WILL %R | -75.000 | -45.161 | -28.846 | -58.818 | -86.170▼ |
| CCI | -48.854 | -60.392 | 42.192 | 28.027 | -61.311 |
|
Friday, October 17, 2025 07:08 AM
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new data from its botensilimab (BOT), a multifunctional, Fc-enhanced CTLA-4 antibody and balstilimab (BAL), a PD-1 ...
|
|
Thursday, October 16, 2025 03:48 AM
Agenus Inc. (“Agenus”) (Nasdaq: AGEN ), a leader in immuno-oncology, will host a virtual Stakeholder Briefing on Tuesday, October 21, 2025, at 4:00 p.m. ET. The webcast will f ...
|
|
Monday, August 11, 2025 04:29 AM
Botensilimab (AGEN1181) is a next-generation, multifunctional, Fc-enhanced CTLA-4 antibody engineered to boost both innate and adaptive anti-tumor immune responses. Its unique design aims to overcome ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/10/25 | 4.09 | 4.22 | 4.09 | 4.15 | 196,318 |
| 24/10/25 | 4.24 | 4.24 | 3.9504 | 4.14 | 401,325 |
| 23/10/25 | 4.05 | 4.24 | 4.04 | 4.18 | 540,029 |
| 22/10/25 | 4.25 | 4.26 | 4.00 | 4.05 | 563,435 |
| 21/10/25 | 4.42 | 4.46 | 4.13 | 4.29 | 480,092 |
| 20/10/25 | 3.97 | 4.5999 | 3.9486 | 4.42 | 928,072 |
| 17/10/25 | 4.00 | 4.10 | 3.85 | 3.88 | 552,074 |
| 16/10/25 | 4.05 | 4.18 | 3.95 | 3.99 | 523,305 |
| 15/10/25 | 3.99 | 4.0075 | 3.84 | 3.98 | 391,805 |
| 14/10/25 | 3.99 | 3.99 | 3.835 | 3.97 | 356,121 |
|
|
||||
|
|
||||
|
|